Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Call for patient organisation representatives to join the Committee for Orphan Medicines 4 December 2017NewsCorporateMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2017 1 December 2017NewsHumanPharmacovigilance Regulatory guidance for pharmaceutical companies to prepare for UK's withdrawal from EU 1 December 2017NewsCorporate Procedural guidance to help pharma companies prepare for Brexit 28 November 2017NewsCorporateBrexit ENCePP: 10 years for excellence in medicines safety 24 November 2017NewsCorporate EU Ombudsman confirms EMA's correct handling of declared interests 24 November 2017NewsCorporate New guidelines on good manufacturing practices for advanced therapies 24 November 2017NewsCorporateCompliance and inspectionsRegulatory and procedural guidance New EudraVigilance system is live 22 November 2017NewsCorporate EMA to relocate to Amsterdam, the Netherlands 20 November 2017Press releaseCorporate Towards a single development programme for new antibiotics in EU, Japan and US 17 November 2017NewsCorporate 1 … 126 127 128 129 130 Page 130 of 380 131 132 133 134 … 380
Call for patient organisation representatives to join the Committee for Orphan Medicines 4 December 2017NewsCorporateMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2017 1 December 2017NewsHumanPharmacovigilance
Regulatory guidance for pharmaceutical companies to prepare for UK's withdrawal from EU 1 December 2017NewsCorporate
New guidelines on good manufacturing practices for advanced therapies 24 November 2017NewsCorporateCompliance and inspectionsRegulatory and procedural guidance
Towards a single development programme for new antibiotics in EU, Japan and US 17 November 2017NewsCorporate